Detalhe da pesquisa
1.
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line.
Eur J Clin Pharmacol
; 80(6): 941-947, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38478093
2.
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
J Oncol Pharm Pract
; : 10781552241241004, 2024 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38613329
3.
The Evaluation of Dietary Antioxidant Capacity, Dietary Inflammatory Index and Serum Biomarkers in Breast Cancer: A Prospective Study.
Nutr Cancer
; 75(8): 1625-1637, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37353899
4.
Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?
Eur J Clin Pharmacol
; 79(4): 485-491, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36749352
5.
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.
Eur J Clin Pharmacol
; 79(2): 243-248, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36520173
6.
Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio.
Support Care Cancer
; 31(6): 357, 2023 May 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37246994
7.
Are dietary and serum advanced glycation end-products related to inflammation and oxidation biomarkers in breast cancer patients: a follow-up study.
Support Care Cancer
; 31(6): 334, 2023 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37183232
8.
Ribociclib-induced hepatotoxicity.
J Oncol Pharm Pract
; 29(5): 1275-1277, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36762416
9.
Dietary Antioxidant Capacity and Serum Inflammatory Biomarkers Levels in Cancer Survivors.
Nutr Cancer
; 74(4): 1243-1251, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-34278894
10.
Ibrutinib and panitumumab used in combination safely in a patient with metachronous colorectal cancer and chronic lymphocytic leukemia.
Anticancer Drugs
; 33(8): 765-767, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35946528
11.
Is pancreatic giant cell tumor resistant to standard chemotherapy?
Anticancer Drugs
; 33(8): 758-760, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35946539
12.
Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.
Eur J Clin Pharmacol
; 78(12): 1973-1979, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36266366
13.
Prospective external validation of an updated algorithm to quantify risk of febrile neutropenia in cancer patients after a cycle of chemotherapy.
Support Care Cancer
; 30(3): 2621-2629, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34816328
14.
Response to first-line chemotherapy regimen is associated with efficacy of immune checkpoint blockade therapies in patients with metastatic urothelial carcinoma.
Int J Clin Oncol
; 27(3): 585-591, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34762201
15.
Nephrotic syndrome induced by cetuximab in a patient with metastatic colorectal cancer.
J Oncol Pharm Pract
; 28(4): 998-1002, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35023411
16.
A case of severe vasculitis after FLOT chemotherapy in a patient with metastatic gastric cancer who received multiple line chemotherapy.
J Oncol Pharm Pract
; 28(5): 1222-1225, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35044279
17.
Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer.
J Oncol Pharm Pract
; 28(3): 740-745, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34935553
18.
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Int J Clin Oncol
; 26(8): 1506-1513, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34023933
19.
Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer.
J Oncol Pharm Pract
; 27(2): 405-413, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33040676
20.
Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor.
J Oncol Pharm Pract
; 27(8): 2049-2052, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33977817